Xencor Logo

Xencor

🇺🇸
XNCR
US98401F1057

Xencor is a U.S.-based biopharmaceutical company specializing in the development of innovative antibody therapeutics. Through its XmAb® technology platform, Xencor optimizes immunotherapy to treat cancer and autoimmune diseases in a targeted and effective manner.

Next Quarterly Earnings

Monday, November 9, 2026
CW 46
After-Hours
In 74 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 12, 2026

Stock Price

Frequently asked questions

When will Xencor report its next quarterly earnings?

Xencor is scheduled to report its next quarterly earnings on 11/09/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Xencor last report quarterly earnings?

Xencor last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.29 USD.

How often has Xencor beaten expectations?

Xencor has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the Xencor earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.31
Actual:
Q2 2026
Beat
Estimate:-$0.80
Actual:-$0.29
Difference:+$0.51
Q1 2026
Missed
Estimate:-$0.67
Actual:-$1.71
Difference:-$1.04
Price reaction (1 day):-5.4 %
Price reaction (7 days):-4.8 %
Q3 2025
Beat
Estimate:-$0.58
Actual:-$0.09
Difference:+$0.49
Q2 2025
Beat
Estimate:-$0.70
Actual:-$0.08
Difference:+$0.62
Q1 2025
Beat
Estimate:-$0.71
Actual:-$0.41
Difference:+$0.30

Earnings statistics

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
-17.9%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Xencor
Ticker Symbol
XNCR
ISIN
US98401F1057
Country
🇺🇸
USA
Sector
More Financial Information